Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer’s Disease Trajectory?
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-240434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Joseph Nowell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Division of Neurology, Faculty of Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Positron-Emission Tomography, Glucose. Die Arbeit nennt 43 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Tau aggregation demonstrates close associations with hypometabolism in Alzheimer’s disease (AD), although differing pathophysiological processes may underlie their development.
Objective
To establish whether tau deposition and glucose metabolism have different trajectories in AD progression and evaluate the utility of global measures of these pathological hallmarks in predicting cognitive deficits.
Methods
279 participants with amyloid-β (Aβ) status, and T1-weighted MRI scans, were selected from the Alzheimer’s Disease Neuroimaging Initiative ( http://adni.loni.usc.edu ). We created the standard uptake value ratio images using Statistical Parametric Mapping 12 for [ 18 F]AV1451-PET (tau) and [ 18 F]FDG-PET (glucose metabolism) scans. Voxel-wise group and single-subject level SPM analysis evaluated the relationship between global [ 18 F]FDG-PET and [ 18 F]AV1451-PET depending on the Aβ status. Linear models assessed whether tau deposition or glucose metabolism better predicted clinical progression.
Results
There was a dissociation between global cerebral glucose hypometabolism and global tau load in amyloid-positive AD and amyloid-negative mild cognitive impairment (MCI) ( p > 0.05). Global hypometabolism was only associated with global cortical tau in amyloid-positive MCI. Voxel-level single subject tau load better predicted neuropsychological performance, Alzheimer’s disease assessment scale-cognitive (ADAS-Cog) 13 score, and one-year change compared with regional and global hypometabolism.
Conclusions
A dissociation between tau pathology and glucose metabolism at a global level in AD could imply that other pathological processes influence glucose metabolism. Furthermore, as tau is a better predictor of clinical progression, these processes may have independent trajectories and require independent consideration in the context of therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain Sciences, Division of Neurology, Faculty of Medicine, Imperial College London, London, UK.
- School of Medicine, Cardiff University, Cardiff, Wales, UK.
Zitieren
APA
Nowell, J., Raza, S., Livingston, N. R., Sivanathan, S., Gentleman, S., & Edison, P. (2024). Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer’s Disease Trajectory?. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240434
Vancouver
Nowell J, Raza S, Livingston NR, Sivanathan S, Gentleman S, Edison P. Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer’s Disease Trajectory?. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240434
BibTeX
@article{Nowell2024,
author = {Nowell, Joseph and Raza, Sanara and Livingston, Nicholas R and Sivanathan, Shayndhan and Gentleman, Steve and Edison, Paul},
title = {Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer’s Disease Trajectory?},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-240434}
}
EUVIMED